Hepatitis Testing Market Size, Share, and Outlook, H2-2025 Report- By Disease (Hepatitis B (HBV), Hepatitis C (HCV), Others), By Technology (Enzyme-linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDT), Polymerase Chain Reaction (PCR), Isotherm
Description
Hepatitis Testing Market Outlook
The global Hepatitis Testing Market Size is valued at $3.3 Billion in 2025 and is forecast to reach $4.6 Billion in 2032 at a CAGR of 4.9%.
The Hepatitis Testing Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Hepatitis Testing Market segments across 22 countries from 2021 to 2032. Key segments covered include By Disease (Hepatitis B (HBV), Hepatitis C (HCV), Others), By Technology (Enzyme-linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (The hepatitis testing market in 2025 is undergoing a transformation driven by the convergence of advanced diagnostic technologies, point-of-care innovations, and global public health initiatives. The increasing prevalence of hepatitis B and C infections, combined with renewed government screening mandates in both developed and developing countries, is sustaining high demand for accurate and rapid testing solutions. Automation and molecular diagnostics are playing a pivotal role, with high-throughput PCR and CLIA-based assays enabling quicker turnaround and improved sensitivity. Partnerships between diagnostic companies and NGOs are expanding access to testing in resource-limited regions, with portable devices gaining traction. In parallel, pharmaceutical research pipelines targeting hepatitis treatments are stimulating demand for companion diagnostics to monitor viral load and treatment response. The market is also seeing a rise in multiplex testing panels that screen for multiple hepatitis types alongside other liver function indicators, streamlining patient evaluation. Artificial intelligence and data analytics are increasingly integrated into test interpretation, reducing human error and improving epidemiological surveillance. Regulatory approvals for innovative assays are accelerating commercialization timelines, creating opportunities for early movers. As healthcare systems move toward universal screening goals, the hepatitis testing market is positioned for robust growth and global impact.T), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Others), By End-User (Hospitals, Diagnostic Laboratories, Blood Banks, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Hepatitis Testing Market Insights, 2025
The hepatitis testing market in 2025 is undergoing a transformation driven by the convergence of advanced diagnostic technologies, point-of-care innovations, and global public health initiatives. The increasing prevalence of hepatitis B and C infections, combined with renewed government screening mandates in both developed and developing countries, is sustaining high demand for accurate and rapid testing solutions. Automation and molecular diagnostics are playing a pivotal role, with high-throughput PCR and CLIA-based assays enabling quicker turnaround and improved sensitivity. Partnerships between diagnostic companies and NGOs are expanding access to testing in resource-limited regions, with portable devices gaining traction. In parallel, pharmaceutical research pipelines targeting hepatitis treatments are stimulating demand for companion diagnostics to monitor viral load and treatment response. The market is also seeing a rise in multiplex testing panels that screen for multiple hepatitis types alongside other liver function indicators, streamlining patient evaluation. Artificial intelligence and data analytics are increasingly integrated into test interpretation, reducing human error and improving epidemiological surveillance. Regulatory approvals for innovative assays are accelerating commercialization timelines, creating opportunities for early movers. As healthcare systems move toward universal screening goals, the hepatitis testing market is positioned for robust growth and global impact.
Five Trends Shaping the Global Hepatitis Testing Market in 2025 and Beyond
The global Hepatitis Testing Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Hepatitis Testing Industry?
The Hepatitis Testing Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Hepatitis Testing Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Hepatitis Testing Market Segment Insights
The Hepatitis Testing Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Disease (Hepatitis B (HBV), Hepatitis C (HCV), Others), By Technology (Enzyme-linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (The hepatitis testing market in 2025 is undergoing a transformation driven by the convergence of advanced diagnostic technologies, point-of-care innovations, and global public health initiatives. The increasing prevalence of hepatitis B and C infections, combined with renewed government screening mandates in both developed and developing countries, is sustaining high demand for accurate and rapid testing solutions. Automation and molecular diagnostics are playing a pivotal role, with high-throughput PCR and CLIA-based assays enabling quicker turnaround and improved sensitivity. Partnerships between diagnostic companies and NGOs are expanding access to testing in resource-limited regions, with portable devices gaining traction. In parallel, pharmaceutical research pipelines targeting hepatitis treatments are stimulating demand for companion diagnostics to monitor viral load and treatment response. The market is also seeing a rise in multiplex testing panels that screen for multiple hepatitis types alongside other liver function indicators, streamlining patient evaluation. Artificial intelligence and data analytics are increasingly integrated into test interpretation, reducing human error and improving epidemiological surveillance. Regulatory approvals for innovative assays are accelerating commercialization timelines, creating opportunities for early movers. As healthcare systems move toward universal screening goals, the hepatitis testing market is positioned for robust growth and global impact.T), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Others), By End-User (Hospitals, Diagnostic Laboratories, Blood Banks, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Hepatitis Testing Industry Value Chain
The chapter identifies potential companies and their operations across the global Hepatitis Testing Industry ecosystem. It assists decision-makers in evaluating global Hepatitis Testing Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Hepatitis Testing Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Hepatitis Testing Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Hepatitis Testing Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Hepatitis Testing Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Hepatitis Testing Market.
Europe Hepatitis Testing Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Hepatitis Testing Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Hepatitis Testing Industry competitiveness. The report analyses the key Hepatitis Testing Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Hepatitis Testing Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Hepatitis Testing Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Hepatitis Testing Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Hepatitis Testing Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Hepatitis Testing Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Hepatitis Testing Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc, Danaher Corp, DiaSorin S.P.A., Epitope Diagnostics Inc, F. Hoffmann-La Roche Ltd, Fujirebio US Inc, geneOmbio Technologies Pvt. Ltd, GenMark Diagnostics Inc, Grifols S.A., MedMira Inc, Meril Life Sciences Pvt. Ltd, Molbio Diagnostics Pvt. Ltd, OraSure Technologies Inc, Ortho Clinical Diagnostics, QIAGEN, Siemens Healthineers AG, Trivitron Healthcare Pvt. Ltd, Vela Diagnostics Pte. Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Hepatitis Testing Market Scope
Leading Segments
By Disease
Hepatitis B (HBV)
Hepatitis C (HCV)
Others
By Technology
Enzyme-linked Immunosorbent Assay (ELISA)
Rapid Diagnostic Tests (The hepatitis testing market in 2025 is undergoing a transformation driven by the convergence of advanced diagnostic technologies, point-of-care innovations, and global public health initiatives. The increasing prevalence of hepatitis B and C infections, combined with renewed government screening mandates in both developed and developing countries, is sustaining high demand for accurate and rapid testing solutions. Automation and molecular diagnostics are playing a pivotal role, with high-throughput PCR and CLIA-based assays enabling quicker turnaround and improved sensitivity. Partnerships between diagnostic companies and NGOs are expanding access to testing in resource-limited regions, with portable devices gaining traction. In parallel, pharmaceutical research pipelines targeting hepatitis treatments are stimulating demand for companion diagnostics to monitor viral load and treatment response. The market is also seeing a rise in multiplex testing panels that screen for multiple hepatitis types alongside other liver function indicators, streamlining patient evaluation. Artificial intelligence and data analytics are increasingly integrated into test interpretation, reducing human error and improving epidemiological surveillance. Regulatory approvals for innovative assays are accelerating commercialization timelines, creating opportunities for early movers. As healthcare systems move toward universal screening goals, the hepatitis testing market is positioned for robust growth and global impact.T)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others
By End-User
Hospitals
Diagnostic Laboratories
Blood Banks
Others
Leading Companies
Abbott Laboratories
bioMérieux SA
Bio-Rad Laboratories Inc
Danaher Corp
DiaSorin S.P.A.
Epitope Diagnostics Inc
F. Hoffmann-La Roche Ltd
Fujirebio US Inc
geneOmbio Technologies Pvt. Ltd
GenMark Diagnostics Inc
Grifols S.A.
MedMira Inc
Meril Life Sciences Pvt. Ltd
Molbio Diagnostics Pvt. Ltd
OraSure Technologies Inc
Ortho Clinical Diagnostics
QIAGEN
Siemens Healthineers AG
Trivitron Healthcare Pvt. Ltd
Vela Diagnostics Pte. Ltd
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Hepatitis Testing Market Size is valued at $3.3 Billion in 2025 and is forecast to reach $4.6 Billion in 2032 at a CAGR of 4.9%.
The Hepatitis Testing Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Hepatitis Testing Market segments across 22 countries from 2021 to 2032. Key segments covered include By Disease (Hepatitis B (HBV), Hepatitis C (HCV), Others), By Technology (Enzyme-linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (The hepatitis testing market in 2025 is undergoing a transformation driven by the convergence of advanced diagnostic technologies, point-of-care innovations, and global public health initiatives. The increasing prevalence of hepatitis B and C infections, combined with renewed government screening mandates in both developed and developing countries, is sustaining high demand for accurate and rapid testing solutions. Automation and molecular diagnostics are playing a pivotal role, with high-throughput PCR and CLIA-based assays enabling quicker turnaround and improved sensitivity. Partnerships between diagnostic companies and NGOs are expanding access to testing in resource-limited regions, with portable devices gaining traction. In parallel, pharmaceutical research pipelines targeting hepatitis treatments are stimulating demand for companion diagnostics to monitor viral load and treatment response. The market is also seeing a rise in multiplex testing panels that screen for multiple hepatitis types alongside other liver function indicators, streamlining patient evaluation. Artificial intelligence and data analytics are increasingly integrated into test interpretation, reducing human error and improving epidemiological surveillance. Regulatory approvals for innovative assays are accelerating commercialization timelines, creating opportunities for early movers. As healthcare systems move toward universal screening goals, the hepatitis testing market is positioned for robust growth and global impact.T), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Others), By End-User (Hospitals, Diagnostic Laboratories, Blood Banks, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Hepatitis Testing Market Insights, 2025
The hepatitis testing market in 2025 is undergoing a transformation driven by the convergence of advanced diagnostic technologies, point-of-care innovations, and global public health initiatives. The increasing prevalence of hepatitis B and C infections, combined with renewed government screening mandates in both developed and developing countries, is sustaining high demand for accurate and rapid testing solutions. Automation and molecular diagnostics are playing a pivotal role, with high-throughput PCR and CLIA-based assays enabling quicker turnaround and improved sensitivity. Partnerships between diagnostic companies and NGOs are expanding access to testing in resource-limited regions, with portable devices gaining traction. In parallel, pharmaceutical research pipelines targeting hepatitis treatments are stimulating demand for companion diagnostics to monitor viral load and treatment response. The market is also seeing a rise in multiplex testing panels that screen for multiple hepatitis types alongside other liver function indicators, streamlining patient evaluation. Artificial intelligence and data analytics are increasingly integrated into test interpretation, reducing human error and improving epidemiological surveillance. Regulatory approvals for innovative assays are accelerating commercialization timelines, creating opportunities for early movers. As healthcare systems move toward universal screening goals, the hepatitis testing market is positioned for robust growth and global impact.
Five Trends Shaping the Global Hepatitis Testing Market in 2025 and Beyond
The global Hepatitis Testing Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Hepatitis Testing Industry?
The Hepatitis Testing Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Hepatitis Testing Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Hepatitis Testing Market Segment Insights
The Hepatitis Testing Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Disease (Hepatitis B (HBV), Hepatitis C (HCV), Others), By Technology (Enzyme-linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (The hepatitis testing market in 2025 is undergoing a transformation driven by the convergence of advanced diagnostic technologies, point-of-care innovations, and global public health initiatives. The increasing prevalence of hepatitis B and C infections, combined with renewed government screening mandates in both developed and developing countries, is sustaining high demand for accurate and rapid testing solutions. Automation and molecular diagnostics are playing a pivotal role, with high-throughput PCR and CLIA-based assays enabling quicker turnaround and improved sensitivity. Partnerships between diagnostic companies and NGOs are expanding access to testing in resource-limited regions, with portable devices gaining traction. In parallel, pharmaceutical research pipelines targeting hepatitis treatments are stimulating demand for companion diagnostics to monitor viral load and treatment response. The market is also seeing a rise in multiplex testing panels that screen for multiple hepatitis types alongside other liver function indicators, streamlining patient evaluation. Artificial intelligence and data analytics are increasingly integrated into test interpretation, reducing human error and improving epidemiological surveillance. Regulatory approvals for innovative assays are accelerating commercialization timelines, creating opportunities for early movers. As healthcare systems move toward universal screening goals, the hepatitis testing market is positioned for robust growth and global impact.T), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Others), By End-User (Hospitals, Diagnostic Laboratories, Blood Banks, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Hepatitis Testing Industry Value Chain
The chapter identifies potential companies and their operations across the global Hepatitis Testing Industry ecosystem. It assists decision-makers in evaluating global Hepatitis Testing Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Hepatitis Testing Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Hepatitis Testing Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Hepatitis Testing Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Hepatitis Testing Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Hepatitis Testing Market.
Europe Hepatitis Testing Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Hepatitis Testing Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Hepatitis Testing Industry competitiveness. The report analyses the key Hepatitis Testing Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Hepatitis Testing Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Hepatitis Testing Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Hepatitis Testing Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Hepatitis Testing Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Hepatitis Testing Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Hepatitis Testing Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc, Danaher Corp, DiaSorin S.P.A., Epitope Diagnostics Inc, F. Hoffmann-La Roche Ltd, Fujirebio US Inc, geneOmbio Technologies Pvt. Ltd, GenMark Diagnostics Inc, Grifols S.A., MedMira Inc, Meril Life Sciences Pvt. Ltd, Molbio Diagnostics Pvt. Ltd, OraSure Technologies Inc, Ortho Clinical Diagnostics, QIAGEN, Siemens Healthineers AG, Trivitron Healthcare Pvt. Ltd, Vela Diagnostics Pte. Ltd. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Hepatitis Testing Market Scope
Leading Segments
By Disease
Hepatitis B (HBV)
Hepatitis C (HCV)
Others
By Technology
Enzyme-linked Immunosorbent Assay (ELISA)
Rapid Diagnostic Tests (The hepatitis testing market in 2025 is undergoing a transformation driven by the convergence of advanced diagnostic technologies, point-of-care innovations, and global public health initiatives. The increasing prevalence of hepatitis B and C infections, combined with renewed government screening mandates in both developed and developing countries, is sustaining high demand for accurate and rapid testing solutions. Automation and molecular diagnostics are playing a pivotal role, with high-throughput PCR and CLIA-based assays enabling quicker turnaround and improved sensitivity. Partnerships between diagnostic companies and NGOs are expanding access to testing in resource-limited regions, with portable devices gaining traction. In parallel, pharmaceutical research pipelines targeting hepatitis treatments are stimulating demand for companion diagnostics to monitor viral load and treatment response. The market is also seeing a rise in multiplex testing panels that screen for multiple hepatitis types alongside other liver function indicators, streamlining patient evaluation. Artificial intelligence and data analytics are increasingly integrated into test interpretation, reducing human error and improving epidemiological surveillance. Regulatory approvals for innovative assays are accelerating commercialization timelines, creating opportunities for early movers. As healthcare systems move toward universal screening goals, the hepatitis testing market is positioned for robust growth and global impact.T)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others
By End-User
Hospitals
Diagnostic Laboratories
Blood Banks
Others
Leading Companies
Abbott Laboratories
bioMérieux SA
Bio-Rad Laboratories Inc
Danaher Corp
DiaSorin S.P.A.
Epitope Diagnostics Inc
F. Hoffmann-La Roche Ltd
Fujirebio US Inc
geneOmbio Technologies Pvt. Ltd
GenMark Diagnostics Inc
Grifols S.A.
MedMira Inc
Meril Life Sciences Pvt. Ltd
Molbio Diagnostics Pvt. Ltd
OraSure Technologies Inc
Ortho Clinical Diagnostics
QIAGEN
Siemens Healthineers AG
Trivitron Healthcare Pvt. Ltd
Vela Diagnostics Pte. Ltd
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
195 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Hepatitis Testing Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Hepatitis Testing Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Hepatitis Testing Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Hepatitis Testing Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Hepatitis Testing Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Disease
- Hepatitis B (HBV)
- Hepatitis C (HCV)
- Others
- By Technology
- Enzyme-linked Immunosorbent Assay (ELISA)
- Rapid Diagnostic Tests (RDT)
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Others
- By End-User
- Hospitals
- Diagnostic Laboratories
- Blood Banks
- Others
- 6. Global Hepatitis Testing Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Hepatitis Testing Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Hepatitis Testing Market Trends and Growth Opportunities
- 6.2.1 North America Hepatitis Testing Market Outlook by Type
- 6.2.2 North America Hepatitis Testing Market Outlook by Application
- 6.3 North America Hepatitis Testing Market Outlook by Country
- 6.3.1 The US Hepatitis Testing Market Outlook, 2021- 2032
- 6.3.2 Canada Hepatitis Testing Market Outlook, 2021- 2032
- 6.3.3 Mexico Hepatitis Testing Market Outlook, 2021- 2032
- 7. Europe Hepatitis Testing Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Hepatitis Testing Market Trends and Growth Opportunities
- 7.2.1 Europe Hepatitis Testing Market Outlook by Type
- 7.2.2 Europe Hepatitis Testing Market Outlook by Application
- 7.3 Europe Hepatitis Testing Market Outlook by Country
- 7.3.2 Germany Hepatitis Testing Market Outlook, 2021- 2032
- 7.3.3 France Hepatitis Testing Market Outlook, 2021- 2032
- 7.3.4 The UK Hepatitis Testing Market Outlook, 2021- 2032
- 7.3.5 Spain Hepatitis Testing Market Outlook, 2021- 2032
- 7.3.6 Italy Hepatitis Testing Market Outlook, 2021- 2032
- 7.3.7 Russia Hepatitis Testing Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Hepatitis Testing Market Outlook, 2021- 2032
- 8. Asia Pacific Hepatitis Testing Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Hepatitis Testing Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Hepatitis Testing Market Outlook by Type
- 8.2.2 Asia Pacific Hepatitis Testing Market Outlook by Application
- 8.3 Asia Pacific Hepatitis Testing Market Outlook by Country
- 8.3.1 China Hepatitis Testing Market Outlook, 2021- 2032
- 8.3.2 India Hepatitis Testing Market Outlook, 2021- 2032
- 8.3.3 Japan Hepatitis Testing Market Outlook, 2021- 2032
- 8.3.4 South Korea Hepatitis Testing Market Outlook, 2021- 2032
- 8.3.5 Australia Hepatitis Testing Market Outlook, 2021- 2032
- 8.3.6 South East Asia Hepatitis Testing Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Hepatitis Testing Market Outlook, 2021- 2032
- 9. South America Hepatitis Testing Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Hepatitis Testing Market Trends and Growth Opportunities
- 9.2.1 South America Hepatitis Testing Market Outlook by Type
- 9.2.2 South America Hepatitis Testing Market Outlook by Application
- 9.3 South America Hepatitis Testing Market Outlook by Country
- 9.3.1 Brazil Hepatitis Testing Market Outlook, 2021- 2032
- 9.3.2 Argentina Hepatitis Testing Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Hepatitis Testing Market Outlook, 2021- 2032
- 10. Middle East and Africa Hepatitis Testing Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Hepatitis Testing Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Hepatitis Testing Market Outlook by Type
- 10.2.2 Middle East and Africa Hepatitis Testing Market Outlook by Application
- 10.3 Middle East and Africa Hepatitis Testing Market Outlook by Country
- 10.3.1 Saudi Arabia Hepatitis Testing Market Outlook, 2021- 2032
- 10.3.2 The UAE Hepatitis Testing Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Hepatitis Testing Market Outlook, 2021- 2032
- 10.3.4 South Africa Hepatitis Testing Market Outlook, 2021- 2032
- 10.3.5 Egypt Hepatitis Testing Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Hepatitis Testing Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Abbott Laboratories
- bioMérieux SA
- Bio-Rad Laboratories Inc
- Danaher Corp
- DiaSorin S.P.A.
- Epitope Diagnostics Inc
- F. Hoffmann-La Roche Ltd
- Fujirebio US Inc
- geneOmbio Technologies Pvt. Ltd
- GenMark Diagnostics Inc
- Grifols S.A.
- MedMira Inc
- Meril Life Sciences Pvt. Ltd
- Molbio Diagnostics Pvt. Ltd
- OraSure Technologies Inc
- Ortho Clinical Diagnostics
- QIAGEN
- Siemens Healthineers AG
- Trivitron Healthcare Pvt. Ltd
- Vela Diagnostics Pte. Ltd
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
